BR112013027122A2 - método e sistema para analisar características de tecido, e, kit - Google Patents

método e sistema para analisar características de tecido, e, kit

Info

Publication number
BR112013027122A2
BR112013027122A2 BR112013027122A BR112013027122A BR112013027122A2 BR 112013027122 A2 BR112013027122 A2 BR 112013027122A2 BR 112013027122 A BR112013027122 A BR 112013027122A BR 112013027122 A BR112013027122 A BR 112013027122A BR 112013027122 A2 BR112013027122 A2 BR 112013027122A2
Authority
BR
Brazil
Prior art keywords
cell
field
tissue characteristics
assessment
observed
Prior art date
Application number
BR112013027122A
Other languages
English (en)
Inventor
Christopher James Sevinsky
Colin Craig Mcculloch
Fiona Ginty
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of BR112013027122A2 publication Critical patent/BR112013027122A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211—Selection of the most significant subset of features
    • G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/771—Feature selection, e.g. selecting representative features from a multi-dimensional feature space
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698—Matching; Classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Abstract

método e sistema para analisar características de tecido, e, kit um conjunto de dados de dados de perfil celular é armazenado. os dados de perfil celular incluem dados de imagem biométrica multiplexada descrevendo a expressão de uma pluralidade de biomarcadores com relação a um campo de visão em que células individuais são delineadas e segmentar em compartimentos. cada célula no campo é atribuída a um único agrupamento em conjunto selecionado de agrupamentos com base em similaridade celular; similaridade celular é determinada com base na pluralidade de atributos de células selecionadas. a proporção de células em cada agrupamento é observada. as proporções observadas são examinadas para uma associação com um diagnóstico, um prognóstico, ou uma resposta derivada de uma associação conhecida do conjunto selecionado de agrupamentos com o, pelo menos, um fragmento de metainformação incluindo a avaliação do nível de campo de visão ou uma avaliação do nível de paciente.
BR112013027122A 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit BR112013027122A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US13/252,078 US20120269419A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,069 US20120270752A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with moments
PCT/EP2012/057394 WO2012143561A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters

Publications (1)

Publication Number Publication Date
BR112013027122A2 true BR112013027122A2 (pt) 2017-01-10

Family

ID=47021377

Family Applications (4)

Application Number Title Priority Date Filing Date
BR112013027125A BR112013027125A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido
BR112013027122A BR112013027122A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BR112013027125A BR112013027125A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, kit
BR112013027124A BR112013027124A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112013027123A BR112013027123A2 (pt) 2011-04-22 2012-04-23 método e sistema para analisar características de tecido, e, método de análise de características de agrupamento de células

Country Status (8)

Country Link
US (5) US20120270752A1 (pt)
EP (4) EP2700042B1 (pt)
JP (4) JP6063446B2 (pt)
BR (4) BR112013027125A2 (pt)
CA (4) CA2833428A1 (pt)
RU (3) RU2013145151A (pt)
SG (4) SG194594A1 (pt)
WO (4) WO2012143556A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
WO2014089494A1 (en) * 2012-12-06 2014-06-12 Clarient Diagnostic Services, Inc. Systems and methods for split screen display of a biological specimen and for capturing records thereof
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
WO2015003178A1 (en) * 2013-07-03 2015-01-08 Coyne Scientific, Llc Methods for predicting responses to chemical or biologic substances
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
CA2971129A1 (en) 2015-01-22 2016-07-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for determining proportions of distinct cell subsets
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
EP3395937A4 (en) * 2015-12-22 2019-08-21 Nikon Corporation IMAGE PROCESSING APPARATUS
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
WO2018151223A1 (ja) * 2017-02-16 2018-08-23 国立大学法人京都大学 細胞評価方法、細胞評価装置、及び細胞評価プログラム
US10127696B2 (en) * 2017-03-22 2018-11-13 Sas Institute Inc. Computer system to generate scalable plots using clustering
WO2018201072A2 (en) * 2017-04-28 2018-11-01 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
US10706328B2 (en) 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
WO2020056372A1 (en) * 2018-09-14 2020-03-19 Krishnan Ramanathan Multimodal learning framework for analysis of clinical trials
WO2020068684A2 (en) 2018-09-24 2020-04-02 Krishnan Ramanathan Hybrid analysis framework for prediction of outcomes in clinical trials
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
WO2020112478A1 (en) * 2018-11-29 2020-06-04 Somalogic, Inc. Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
WO2023033056A1 (ja) * 2021-09-01 2023-03-09 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
EP4224488A1 (en) 2022-02-02 2023-08-09 Aizoon S.r.l. Method for the prognosis of a disease following upon a therapeutic treatment, and corresponding system and computer program product
EP4250301A1 (en) 2022-03-24 2023-09-27 Aizoon S.r.l. Method for estimating a variable of interest associated to a given disease as a function of a plurality of different omics data, corresponding device, and computer program product
US20240028964A1 (en) 2022-07-25 2024-01-25 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
EP1425302A2 (en) * 2001-01-24 2004-06-09 Protein Design Labs Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2003255332A1 (en) * 2002-07-30 2004-02-23 Steinbeis-Transferzentrum Analytische Elektronenmikroskopie, Biomedizin, Biotechnologie-Heidelberg Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
US20060275844A1 (en) * 2005-04-19 2006-12-07 Linke Steven P Diagnostic markers of breast cancer treatment and progression and methods of use thereof
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
CA2652562C (en) * 2006-05-17 2015-05-12 Cellumen, Inc. Method for automated tissue analysis
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
CA2678919A1 (en) * 2007-03-27 2008-10-02 Ranit Aharonov Gene expression signature for classification of cancers
CA2683134A1 (en) * 2007-05-07 2008-11-13 Ge Healthcare Bio-Sciences Corp. System and method for the automated analysis of cellular assays and tissues
ES2374686T3 (es) * 2007-05-14 2012-02-21 Historx, Inc. Separación en compartimentos por caracterización de píxel usando agrupamiento de datos de imágenes.
WO2009108215A1 (en) * 2007-09-06 2009-09-03 Aviaradx, Inc. Tumor grading and cancer prognosis
EP2332087B1 (en) * 2008-07-25 2020-04-22 Fundação D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud Systems and methods of treating, diagnosing and predicting the occurrence of a medical condition
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US8320655B2 (en) * 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Also Published As

Publication number Publication date
BR112013027125A2 (pt) 2017-01-10
RU2013145151A (ru) 2015-05-27
EP2700036A2 (en) 2014-02-26
JP6063447B2 (ja) 2017-01-18
CA2833295A1 (en) 2012-10-26
SG194592A1 (en) 2013-12-30
US20140185905A1 (en) 2014-07-03
WO2012143561A2 (en) 2012-10-26
SG194590A1 (en) 2013-12-30
JP2014517954A (ja) 2014-07-24
WO2012143562A2 (en) 2012-10-26
RU2013145162A (ru) 2015-05-27
EP2700038A2 (en) 2014-02-26
EP2700042B1 (en) 2021-03-17
EP2700037A2 (en) 2014-02-26
CA2833497A1 (en) 2012-10-26
WO2012143561A3 (en) 2013-05-23
JP2014521926A (ja) 2014-08-28
SG194594A1 (en) 2013-12-30
WO2012143562A3 (en) 2013-02-28
SG194588A1 (en) 2013-12-30
BR112013027124A2 (pt) 2017-01-10
WO2012143558A3 (en) 2012-12-20
JP2014521925A (ja) 2014-08-28
EP2700042A2 (en) 2014-02-26
CA2833804A1 (en) 2012-10-26
JP6063446B2 (ja) 2017-01-18
RU2013145154A (ru) 2015-05-27
US20120269419A1 (en) 2012-10-25
JP2014516413A (ja) 2014-07-10
WO2012143558A2 (en) 2012-10-26
US20120271553A1 (en) 2012-10-25
BR112013027123A2 (pt) 2017-01-10
JP6163152B2 (ja) 2017-07-12
JP6143743B2 (ja) 2017-06-07
US20120270752A1 (en) 2012-10-25
US20120269418A1 (en) 2012-10-25
EP2700038B1 (en) 2021-04-21
WO2012143556A3 (en) 2013-05-30
CA2833428A1 (en) 2012-10-26
WO2012143556A2 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
BR112013027122A2 (pt) método e sistema para analisar características de tecido, e, kit
JP2014517954A5 (pt)
BR112018015698A2 (pt) ?métodos diagnósticos e prognósticos para doenças cardiovasculares e eventos?
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
BR112016010322A2 (pt) Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão
BR112013003391A2 (pt) biomarcadores de câncer pancreático e usos dos mesmos
EA201270650A1 (ru) Транскрипционная сигнатура крови активной инфекции mycobacterium tuberculosis по сравнению с латентной
BR112015029472A2 (pt) métodos de descoberta e medições para células pequenas em sistemas ofdm/ofdma
BR112014025246A8 (pt) método para classificação de uma amostra em uma de pelo menos duas classes com base em dados espectrais, método para criar um banco de dados para uso na classificação de uma amostra em uma de pelo menos duas classes com base em dados espectrais, programa de computador, meio de armazenagem de dados, e sistema para classificar uma amostra com base em dados espectrais
BR112015031639A2 (pt) integração alvo
BR112015017767A2 (pt) sistema para detectar estágios do sono de um indivíduo, método para detectar estágios do sono de um indivíduo, e, sistema configurado para detectar estágios do sono de um indivíduo
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
BR112017025254A2 (pt) ?métodos para detecção de pelo menos uma mutação em uma pluralidade de genes relacionados ao câncer, selecionar um indivíduo para tratamento e prever a probabilidade de capacidade de resposta ao tratamento?
Etheridge et al. The integrin-adhesome is required to maintain muscle structure, mitochondrial ATP production, and movement forces in Caenorhabditis elegans
BR112014006432A2 (pt) biomarcadores do câncer de pulmão e seus usos
BR112014029233A8 (pt) método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
BR112018010168A8 (pt) métodos para detecção de variações de número de cópia no sequenciamento de próxima geração
Sodek et al. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT)
EA201591045A1 (ru) Способ и система идентификации дефектов стекла
BR102012002812A8 (pt) método para determinar a influência de uma variável em um fenômeno
BR112014015498A8 (pt) método; sistema; e meio de armazenamento legível em computador não transitório
Wu et al. A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival
Chen et al. Trophinin-associated protein expression is an independent prognostic biomarker in lung adenocarcinoma
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
BR112017004179A2 (pt) métodos e composições para obter uma avaliação de tuberculose em um indivíduo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]